The value of procalsitonin in determining the severity acute pancreatitis cases

Abstract

Objectives: Many markers and indication systems are being used to indicate the prognosis of acute pancreatitis. Our study was planned to investigate the importance of procalcitonin(PCT) in patients with severe pancreatitis in terms of predicting prognosis by comparing C-reactive protein , modified CT severity index, and duration of hospitalization.
 Methods: In our cross-sectional retrospective study, 30 patients who were hospitalized with a diagnosis of A. pancreatitis were included in the study. Our study was conducted from January 2013 to January 2019 at Katip Çelebi University. PCT, CRP, duration of hospitalization, gender, age, CRE, CA, pleural effusion, and modified CT severity scores were recorded in all patients.
 Results: Of the 30 patients included in the study,13 (43.33%) were male and 17(56.66%) were female. The presence of stones in 80% of patients was detected in 6.7% of patients due to hypertriglestrimia. The PCT value was found to be a minimum of 0.0 ng/ml, a maximum of 39.68 ng/ml, and an average of 1.97 ng/ml. There is a significant relationship between the PCT value and the length of hospitalization for the patients. The hospitalization period was a minimum of 3 days, a maximum of 23 days, and an average of 10.13 days in the 30 patients studied. It was determined that there was a statistically significant relationship between PCT and length of stay (r = 0.437; p 0.016).
 Conclusion: In patients with A. pancreatitis, the evaluation of PCT, CRP, and modified CT severity index can be used to estimate the duration of hospitalization.